KIF15 and lymphoma: Likewise, in the Oncomine database, the expression level of KIF15 was significantly increased in bladder, brain and CNS, breast, cervical, colorectal, esophageal, gastric, head and neck, lung, and ovarian cancers, as well as lymphoma and sarcoma; while significantly decreased in leukemia.